Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 3.000
+0.050 (1.69%)
Aug 15, 2025, 4:35 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 20.92 million as of August 15, 2025. Its market cap has decreased by -62.48% in one year.
Market Cap
20.92M
Enterprise Value
13.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 20.92M, a decrease of -61.09%. That is a compound annual growth rate of -20.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 20.92M | -41.08% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 56.72B |
| Haleon | 32.11B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |